Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Second phase II trial for GVAX pancreatic cancer vaccine

May 31, 2002

Clinical data on one of Igeneon's cancer vaccine candidates discussed at ASCO meeting

May 31, 2002

Oncophage granted orphan drug status in renal cell carcinoma

May 30, 2002

IND filed for MDX-060

May 30, 2002

Intralesional CpG ODN evaluated in patients with basal cell carcinoma and melanoma

May 28, 2002

Sosei licenses KS Biomedix's TransMID product for recurrent high-grade glioma in Japan

May 28, 2002

Phase I EMD-72000 results presented at ASCO

May 28, 2002

Pharmexa prepares to file IND for AutoVac HER-2 Protein pharmaccine for breast cancer

May 27, 2002

Biomira updates progress of Theratope and BLP25

May 27, 2002

Antisense oligonucleotide targeting TGF-beta2 shows promise for malignant glioma, other solid tumors

May 24, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...